Home
Live Updates
Aurinia Submits IND Application to US Food & Drug Administration for AUR 200 : vimarsana.com
Aurinia Submits IND Application to US Food & Drug Administration for AUR 200
AUR200, a potent recombinant fusion protein, has a clinically validated MOA with a high affinity for targeting both BAFF and APRIL
Upon FDA clearance of the IND, AUR 200 will be studied in a...
Related Keywords
Maryland ,
United States ,
Rockville ,
Volker Knappertz ,
Research Development ,
Nasdaq ,
Drug Administration ,
American College Of Rheumatology Convergence ,
Aurinia Pharmaceuticals ,
Aurinia Pharmaceuticals Inc ,
Investigational New Drug ,
B Cell Activating Factor ,
Proliferation Inducing Ligand ,
Executive Vice President ,
American College ,
Rheumatology Convergence ,
Increased Potency ,
Accessed December ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.